---
figid: PMC6003288__bctt-10-089Fig2
figtitle: 'Luteolin inhibition of receptor-mediated tumor progression.Notes: Involvement
  of luteolin (green) in modifying processes necessary for metastasis'
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Gallus gallus
- Corynephage beta
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Gallus gallus
- Drosophila melanogaster
pmcid: PMC6003288
filename: bctt-10-089Fig2.jpg
figlink: /pmc/articles/PMC6003288/figure/f2-bctt-10-089/
number: F2
caption: 'Luteolin inhibition of receptor-mediated tumor progression.Notes: Involvement
  of luteolin (green) in modifying processes necessary for metastasis. Notch activation
  results in removal of the intracellular domain of the membrane-bound Notch receptor,
  creating the NICD. NICD is blocked by luteolin through an undetermined mechanism.
  Wnt/β-catenin inhibits GSK3 activity upon activation. Luteolin blocks Wnt-induced
  phosphorylation of GSK3, and thus prevents GSK3 inhibition. Luteolin has been shown
  to inhibit RTK activities and their downstream effectors (see text for specific
  RTKs and associated effector responses). Possible outcomes for each receptor pathway
  are in the corresponding colored boxes. Intracellular proteins color-coded as protein
  kinases (blue), TCFs (gray), and other proteins (brown). Dashed line represents
  possible luteolin interaction.Abbreviations: EMT, epithelial–mesenchymal transition;
  JAK, Janus kinase; Lu, luteolin; NICD, notch intracellular domain; RSK, ribosomal
  S6 kinase; RTK, receptor tyrosine kinase; TCF, transcription factor.'
papertitle: Mechanism of metastasis suppression by luteolin in breast cancer.
reftext: Matthew T Cook. Breast Cancer (Dove Med Press). 2018;10:89-100.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9582847
figid_alias: PMC6003288__F2
figtype: Figure
redirect_from: /figures/PMC6003288__F2
ndex: 63442e77-dede-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6003288__bctt-10-089Fig2.html
  '@type': Dataset
  description: 'Luteolin inhibition of receptor-mediated tumor progression.Notes:
    Involvement of luteolin (green) in modifying processes necessary for metastasis.
    Notch activation results in removal of the intracellular domain of the membrane-bound
    Notch receptor, creating the NICD. NICD is blocked by luteolin through an undetermined
    mechanism. Wnt/β-catenin inhibits GSK3 activity upon activation. Luteolin blocks
    Wnt-induced phosphorylation of GSK3, and thus prevents GSK3 inhibition. Luteolin
    has been shown to inhibit RTK activities and their downstream effectors (see text
    for specific RTKs and associated effector responses). Possible outcomes for each
    receptor pathway are in the corresponding colored boxes. Intracellular proteins
    color-coded as protein kinases (blue), TCFs (gray), and other proteins (brown).
    Dashed line represents possible luteolin interaction.Abbreviations: EMT, epithelial–mesenchymal
    transition; JAK, Janus kinase; Lu, luteolin; NICD, notch intracellular domain;
    RSK, ribosomal S6 kinase; RTK, receptor tyrosine kinase; TCF, transcription factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ras
  - Hras
  - Kras
  - Rem1
  - Akt1
  - Pik3r1
  - Pten
  - Gsk3b
  - Ephb2
  - Mapk1
  - Trp53
  - Foxo3
  - Nfkb1
  - Mtor
  - Rps6ka1
  - Ctnnb1
  - Itk
  - Slc22a3
  - NOTCH1
  - NOTCH2
  - NOTCH3
  - NOTCH4
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - JAK1
  - JAK2
  - JAK3
  - TYK2
  - KRAS
  - HRAS
  - NRAS
  - AKT1
  - AKT2
  - AKT3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - SOAT1
  - STAT1
  - STAT2
  - STAT3
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - PTEN
  - GSK3B
  - EPHB2
  - MAPK1
  - MAPK3
  - TP53
  - TP63
  - TP73
  - FOXO3
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - MTOR
  - RPS6KA1
  - RPS6KA2
  - RPS6KA3
  - RPS6KA4
  - RPS6KA5
  - RPS6KA6
  - RPS6KB1
  - RPS6KB2
  - GSK3A
  - CTNNB1
  - HNF4A
  - CCND1
  - CCND2
  - CCND3
  - ITK
  - SLC22A3
  - Notch1
  - Pik3cg
  - Ephb1
  - Tp53
  - Rela
  - .na.character
  - fz
  - Tie
  - Ras85D
  - InR
  - hop
  - bsk
  - Ras64B
  - Akt
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Stat92E
  - sgg
  - Axn
  - gskt
  - Erk7
  - rl
  - p53
  - betaTub60D
  - hth
  - Dif
  - dl
  - Rel
  - Tor
  - S6kII
  - arm
  - pan
  - CycD
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Lu
  - Cancer
---
